These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17847117)

  • 1. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.
    Lin E; Cavanaugh JE; Leak RK; Perez RG; Zigmond MJ
    J Neurosci Res; 2008 Jan; 86(1):108-17. PubMed ID: 17847117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress.
    Cavanaugh JE; Jaumotte JD; Lakoski JM; Zigmond MJ
    J Neurosci Res; 2006 Nov; 84(6):1367-75. PubMed ID: 16941494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells.
    Fan Y; Li J; Zhang YQ; Jiang LH; Zhang YN; Yan CQ
    Neurol Res; 2014 Jan; 36(1):53-64. PubMed ID: 24107416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
    J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway.
    Huang HY; Lin SZ; Kuo JS; Chen WF; Wang MJ
    Neurobiol Aging; 2007 Aug; 28(8):1258-69. PubMed ID: 16839644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK.
    Ugarte SD; Lin E; Klann E; Zigmond MJ; Perez RG
    J Neurosci Res; 2003 Jul; 73(1):105-12. PubMed ID: 12815714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.
    Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J
    J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Hydroxydopamine induces mitochondrial ERK activation.
    Kulich SM; Horbinski C; Patel M; Chu CT
    Free Radic Biol Med; 2007 Aug; 43(3):372-83. PubMed ID: 17602953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.
    Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK
    Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells.
    Park HJ; Park KH; Shin KS; Lee MK
    Toxicol In Vitro; 2013 Dec; 27(8):2233-41. PubMed ID: 24055892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
    Izumi Y; Sawada H; Sakka N; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
    J Neurosci Res; 2005 Mar; 79(6):849-60. PubMed ID: 15712215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK.
    Jeon ES; Lee MJ; Sung SM; Kim JH
    J Cell Biochem; 2007 Apr; 100(6):1536-47. PubMed ID: 17131361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
    Jiang Z; Yu PH
    Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK.
    Choi WS; Yoon SY; Oh TH; Choi EJ; O'Malley KL; Oh YJ
    J Neurosci Res; 1999 Jul; 57(1):86-94. PubMed ID: 10397638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.
    Choi WS; Eom DS; Han BS; Kim WK; Han BH; Choi EJ; Oh TH; Markelonis GJ; Cho JW; Oh YJ
    J Biol Chem; 2004 May; 279(19):20451-60. PubMed ID: 14993216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways.
    Ge KL; Chen WF; Xie JX; Wong MS
    J Ethnopharmacol; 2010 Jan; 127(1):118-23. PubMed ID: 19799986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration.
    Oh CK; Han BS; Choi WS; Youdim MB; Oh YJ
    Apoptosis; 2011 Nov; 16(11):1087-100. PubMed ID: 21739275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway.
    Fujita H; Ogino T; Kobuchi H; Fujiwara T; Yano H; Akiyama J; Utsumi K; Sasaki J
    Brain Res; 2006 Oct; 1113(1):10-23. PubMed ID: 16945353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced ERK dependent CREB activation reduces apoptosis in staurosporine-treated human neuroblastoma SK-N-BE(2)C cells.
    Park EM; Cho S
    Neurosci Lett; 2006 Jul; 402(1-2):190-4. PubMed ID: 16678346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.